{"filings":[{"id":1361517,"accession_number":"0001628280-26-046247","cik":1756655,"company_name":"Ardent Health, Inc.","ticker":"ARDT","form_type":"8-K","filed_at":"2026-06-30T20:33:53+00:00","items":["5.02","9.01"],"status":"ready","headline":"Ardent Health finalizes separation agreement with ex-CEO Bonick; severance 2x salary+bonus, 12-month non-compete","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Martin Bonick's employment terminated June 2, 2026; separation agreement signed June 26, 2026.","Severance: cash payments equal to 2x (annual salary + target bonus) paid over time.","COBRA health coverage reimbursed for up to 18 months following separation.","Bonick subject to 12-month non-compete within 50-mile radius of company facilities.","Equity vesting (RSUs, PRSUs, RSAs) governed by existing award agreements."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1347490290.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":806598,"accession_number":"0001193125-26-253567","cik":1756655,"company_name":"Ardent Health, Inc.","ticker":"ARDT","form_type":"8-K","filed_at":"2026-06-02T20:23:36+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Ardent Health appoints Dave Caspers as CEO, reaffirms FY 2026 EBITDA guidance","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Dave Caspers appointed President and CEO, effective June 2, 2026, succeeding Marty Bonick.","Caspers receives $900k base salary, 105% target bonus, RSUs ($1.05M) and PRSUs ($1.95M target).","Company reaffirms FY 2026 Adjusted EBITDA guidance of $485M-$535M despite Q2 volume softness.","CFO says Q2 volume softness observed; IMPACT program accelerated to improve margins.","Caspers also appointed to Board of Directors."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1347490290.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":668756,"accession_number":"0001628280-26-038152","cik":1756655,"company_name":"Ardent Health, Inc.","ticker":"ARDT","form_type":"8-K","filed_at":"2026-05-26T20:37:35+00:00","items":["5.07"],"status":"ready","headline":"Ardent Health shareholders elect 11 directors and approve say-on-pay at 2026 annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All 11 director nominees elected with strong support; Mark Sotir received 90.7M for, 861K withhold.","Advisory say-on-pay passed with 91.1M for, 300.7K against, and 184.5K abstentions.","Ratification of Ernst & Young as auditor approved with 97.9M for, 918K against, and 7.8K abstentions.","Broker non-votes were 7.2M for director elections and say-on-pay, none for auditor ratification.","Approximately 98.8M of 143.1M outstanding shares were voted (69% turnout)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"market_cap_usd":1347490290.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":95221,"accession_number":"0001628280-26-030552","cik":1756655,"company_name":"Ardent Health, Inc.","ticker":"ARDT","form_type":"8-K","filed_at":"2026-05-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ardent Health Q1 2026: Revenue $1.60B (+7%), Adjusted EBITDA $124M (+26%), Reaffirms FY Guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue $1.602B (+7.0% YoY); net income $40M ($0.28 diluted EPS) vs $41M ($0.29) a year ago.","Adjusted EBITDA $124M (+26.3% YoY); excluding $10.9M gain, growth was 15%.","Adjusted admissions +2.0%, total surgeries +1.2%; admissions -1.1% due to severe weather and light respiratory season.","Reaffirmed FY2026 guidance: revenue $6.4–$6.7B, Adj EBITDA $485–$535M, diluted EPS $0.90–$1.27.","Lease-adjusted net leverage improved to 2.6x from 3.0x a year ago; cash $610M, total debt $1.1B."],"consensus_eps_estimate":null,"consensus_eps_actual":0.28,"consensus_revenue_estimate":null,"consensus_revenue_actual":1601870000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1347490290.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":108122,"accession_number":"0001628280-26-021738","cik":1756655,"company_name":"Ardent Health, Inc.","ticker":"ARDT","form_type":"8-K","filed_at":"2026-03-27T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"President of Hospital Services Ethan Chernin leaves Ardent Health on March 24, 2026","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Ethan Chernin ceased as President, Hospital Services effective March 24, 2026.","Departure treated as a Qualifying Termination under the Executive Severance Plan.","Chernin eligible for severance benefits per terms described in prior SEC filings.","No replacement named for the President, Hospital Services role at this time."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":1347490290.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":108121,"accession_number":"0001628280-26-014640","cik":1756655,"company_name":"Ardent Health, Inc.","ticker":"ARDT","form_type":"8-K","filed_at":"2026-03-04T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ardent Health Q4 adj EBITDA down 26.6% to $134M; 2026 guidance issued","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 total revenue $1.605B (flat YoY); net income $45M vs $114M prior year.","Q4 adjusted EBITDA $134M (down 26.6% YoY) due to annualization of prior-year benefits.","Full-year 2025 revenue $6.32B (+6%); adjusted EBITDA $545M (+9.3%); margin +20bps to 8.6%.","2026 guidance: revenue $6.4B-$6.7B, adjusted EBITDA $485M-$535M, reflecting headwinds.","Net leverage improved to 0.8x; operating cash flow $471M (+49% YoY); share buyback $3M in Q4."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1347490290.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":124532,"accession_number":"0001628280-25-052879","cik":1756655,"company_name":"Ardent Health, Inc.","ticker":"ARDT","form_type":"8-K","filed_at":"2025-11-18T23:59:59+00:00","items":["7.01","2.03","9.01"],"status":"ready","headline":"Ardent Health authorizes $50M share repurchase program; $609M cash on hand","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board authorized up to $50M in common stock repurchases; no expiration date.","CEO Marty Bonick cites conviction in business fundamentals and strong balance sheet.","Q3 2025 liquidity: $609M cash, lease-adjusted net leverage of 2.5x.","Program funded from existing cash; does not affect ability to pursue M&A or growth."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":1347490290.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":124531,"accession_number":"0001628280-25-051634","cik":1756655,"company_name":"Ardent Health, Inc.","ticker":"ARDT","form_type":"8-K","filed_at":"2025-11-12T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ardent Health Q3 net loss $23M; cuts 2025 adj. EBITDA guidance to $530-555M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $1.58B (+8.8% YoY); net loss attributable of $23M vs net income $26M in Q3 2024.","Adjusted EBITDA $143M (+46.3% YoY); excludes $43M revenue cut from accounting estimate change.","Professional liability reserves increased by $54M from adverse New Mexico claims (single provider, 2019-2022).","2025 adj. EBITDA guidance revised down to $530-555M (prior $575-615M) on higher professional fees & payor denials.","Workforce optimization, contract renegotiations launched to mitigate pressures; liquidity $904M, net leverage 1.0x."],"consensus_eps_estimate":null,"consensus_eps_actual":0.64,"consensus_revenue_estimate":null,"consensus_revenue_actual":4719260000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":1347490290.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":141216,"accession_number":"0001628280-25-042486","cik":1756655,"company_name":"Ardent Health, Inc.","ticker":"ARDT","form_type":"8-K","filed_at":"2025-09-23T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Ardent Health amends $777.5M term loan facility; rate cut 50 bps, maturity extended to 2032","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Interest rate reduced by 50 bps to Term SOFR + 2.25%; expected annual interest savings of ~$3.9M.","Maturity extended from August 2028 to September 2032, enhancing financial flexibility.","ABL credit agreement also amended to align covenant baskets; no material changes or maturity extension.","CFO Alfred Lumsdaine cites continued confidence of lending partners and support for growth strategy."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":1347490290.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":141215,"accession_number":"0001756655-25-000013","cik":1756655,"company_name":"Ardent Health, Inc.","ticker":"ARDT","form_type":"8-K","filed_at":"2025-08-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ardent Health Q2 revenue up 12% to $1.65B; Adj EBITDA +39% to $170M; reaffirms FY25 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income $73M ($0.52 diluted EPS) vs $43M ($0.34) prior year; adjusted EBITDA $170M.","Total revenue $1.645B (+11.9% YoY) driven by 1.6% adjusted admission growth and 10.2% revenue per adjusted admission.","Admissions +6.6% YoY; inpatient surgeries +9.2% but outpatient surgeries -3.8%.","Lease-adjusted net leverage ratio improved to 2.7x from 3.0x in Q1; available liquidity $835M.","Reaffirms FY25 guidance: revenue $6.2-6.45B, Adj EBITDA $575-615M, diluted EPS $1.73-2.01."],"consensus_eps_estimate":null,"consensus_eps_actual":0.81,"consensus_revenue_estimate":null,"consensus_revenue_actual":3142514000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":1347490290.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":159021,"accession_number":"0001756655-25-000009","cik":1756655,"company_name":"Ardent Health, Inc.","ticker":"ARDT","form_type":"8-K","filed_at":"2025-06-20T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Ardent Health President of Hospital Operations David Schultz Departs","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["David Schultz no longer serves as President, Hospital Operations, effective June 16, 2025.","Departure treated as a 'Qualifying Termination' under the company's Executive Severance Plan.","Schultz eligible for severance benefits per plan terms; no replacement named."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":1347490290.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":159020,"accession_number":"0001628280-25-027604","cik":1756655,"company_name":"Ardent Health, Inc.","ticker":"ARDT","form_type":"8-K","filed_at":"2025-05-23T23:59:59+00:00","items":["5.03","5.07","9.01"],"status":"ready","headline":"Ardent Health Partners changes name to Ardent Health, Inc. effective June 3, 2025","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Name change to Ardent Health, Inc.; effective June 3, 2025; NYSE ticker ARDT unchanged.","Board approved amendment; stockholder approval not required under Delaware law.","Annual meeting on May 21, 2025: 11 directors elected; say-on-pay approved with ~98.8% for.","Say-on-pay frequency set to annual until next vote; Ernst & Young ratified as auditor for FY2025.","No change to stockholder rights, CUSIP number, or trading symbol."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":1347490290.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":159019,"accession_number":"0001628280-25-022722","cik":1756655,"company_name":"Ardent Health, Inc.","ticker":"ARDT","form_type":"8-K","filed_at":"2025-05-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ardent Health Q1 net income $41M, revenue $1.50B up 4% YoY; reaffirms FY guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income attributable to Ardent Health $41M ($0.29 diluted EPS), up from $27M a year ago.","Total revenue $1.50B, up 4.0% YoY; admissions +7.6%, adjusted admissions +2.7%.","Adjusted EBITDA $98M, up 2.5% YoY; reaffirms FY2025 guidance: rev $6.2B-$6.45B, Adj. EBITDA $575M-$615M.","Net patient service revenue per adjusted admission +1.2% YoY; lease-adjusted net leverage 3.0x; liquidity $790M."],"consensus_eps_estimate":null,"consensus_eps_actual":0.29,"consensus_revenue_estimate":null,"consensus_revenue_actual":1497234000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1347490290.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":159018,"accession_number":"0001628280-25-016620","cik":1756655,"company_name":"Ardent Health, Inc.","ticker":"ARDT","form_type":"8-K","filed_at":"2025-04-03T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Ardent Health appoints Robert A. DeMichiei to board; former UPMC CFO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Board expanded to 11 members; DeMichiei fills newly created seat effective April 2, 2025.","DeMichiei served as EVP and CFO of UPMC (2004–2020), driving financial growth and M&A.","Will serve on Audit & Compliance Committee and Nominating & Corporate Governance Committee.","Also serves on boards of Waystar (WAY), Ampco-Pittsburgh (AP), and as advisor to Health Catalyst (HCAT).","Over 30 years of finance and healthcare leadership, including roles at GE and PwC."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":1347490290.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":177462,"accession_number":"0001628280-25-015672","cik":1756655,"company_name":"Ardent Health, Inc.","ticker":"ARDT","form_type":"8-K","filed_at":"2025-03-31T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Ardent Health appoints Dave Caspers as COO effective March 31, 2025; three senior leaders promoted","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Caspers joins from Walmart Health (VP omnichannel); prior roles include Banner Health VP operations overseeing 30 hospitals, 350 clinics.","Compensation: base salary $700k, target bonus 90% of base, equity target 1.75x base, sign-on cash $75k plus $100k in stock.","Promotions: Anika Gardenhire to chief digital & transformation officer; Rebecca Kirkham to SVP chief communications; Reed Smith to SVP chief consumer officer.","Caspers oversees operations across 30 hospitals and 280 sites of care in six states, focusing on strategic growth and operational excellence."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":1347490290.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":177461,"accession_number":"0001628280-25-008185","cik":1756655,"company_name":"Ardent Health, Inc.","ticker":"ARDT","form_type":"8-K","filed_at":"2025-02-26T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ardent Health Q4 revenue $1.61B (+19% YoY); Adj EBITDA $183M (+213%); issues 2025 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 net income $114M ($0.81 diluted EPS) vs net loss $4M in Q4 2023.","Full-year 2024 revenue $5.97B (+10.3%); Adj EBITDA $498M (+58.4%); margin expanded 260bps to 8.4%.","2025 guidance: revenue $6.2-6.45B, Adj EBITDA $575-615M, EPS $1.73-2.01.","New Mexico directed payment contributed $94M revenue and $65M Adj EBITDA in Q4; full-year excluding it met/exceeded guidance.","Acquired 18 NextCare urgent care clinics on Jan 3, 2025; cash position $557M."],"consensus_eps_estimate":null,"consensus_eps_actual":1.58,"consensus_revenue_estimate":null,"consensus_revenue_actual":5966072000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":1347490290.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":177460,"accession_number":"0001628280-25-001368","cik":1756655,"company_name":"Ardent Health, Inc.","ticker":"ARDT","form_type":"8-K","filed_at":"2025-01-13T23:59:59+00:00","items":["2.02","7.01","5.02","9.01"],"status":"ready","headline":"Ardent Health provides preliminary 2025 guidance; CMS approves NM directed payment program","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["CMS approved New Mexico directed payment program for July-December 2024; material Q4 financial benefit expected, amount not yet disclosed.","Preliminary 2025 guidance: revenue growth mid-single digits plus ~$200M from NM and OK programs; adj. EBITDA mid-single digits plus ~$140M incremental.","CEO Martin Bonick new base salary $1,076,000; CFO Alfred Lumsdaine base salary $628,000 under amended employment agreements effective Jan 10, 2025.","CEO severance: 2x (salary + target bonus) for non-CIC, 3x for CIC; CFO severance: 1.5x non-CIC, 2x for CIC.","Management reiterates intent to provide formal 2025 guidance in February 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1347490290.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":194191,"accession_number":"0001756655-24-000010","cik":1756655,"company_name":"Ardent Health, Inc.","ticker":"ARDT","form_type":"8-K","filed_at":"2024-11-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ardent Health Q3 revenue $1.45B (+5.2%); adj. EBITDA $98M (+15.3%)","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income of $26M ($0.19 per share); cash from ops of $90M.","Adjusted admissions grew 3.8% YoY; net patient service revenue per adjusted admission up 0.9%.","Adjusted EBITDAR of $138M; margin expanded 50 bps.","Full-year 2024 adjusted EBITDA and revenue guidance increased."],"consensus_eps_estimate":null,"consensus_eps_actual":0.74,"consensus_revenue_estimate":null,"consensus_revenue_actual":4359783000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1347490290.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":210517,"accession_number":"0001628280-24-037235","cik":1756655,"company_name":"Ardent Health, Inc.","ticker":"ARDT","form_type":"8-K","filed_at":"2024-08-14T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ardent Health Q2 revenue $1.47B, adj. EBITDA $122M (+20%); issues FY24 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 revenue $1.47B (+7.5% YoY); net income attributable $43M ($0.34/share).","Adjusted EBITDA $122M, up 20% YoY; adjusted admissions +3.4%.","Full-year 2024 guidance: revenue $5.75-5.90B, Adj. EBITDA $415-435M.","Cash from ops $120M (+$77M YoY); prepaid $100M term loan; net leverage 2.3x.","IPO net proceeds $209M (13.8M shares at $16); pro forma liquidity ~$832M."],"consensus_eps_estimate":null,"consensus_eps_actual":0.55,"consensus_revenue_estimate":null,"consensus_revenue_actual":2909966000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":1347490290.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}